A288980 Share Price Performance
₩1,131.00
-472.00 (-29.44%)
Price ₩1,131.00
Share Price₩1,131.00
Moadata Co., Ltd.'s (KOSDAQ:288980) 25% Share Price Plunge Could Signal Some Risk
Mar 24
Moadata Co., Ltd. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
A288980 Community Narratives
There are no narratives available yet.
Recent A288980 News & Updates
Is Moadata (KOSDAQ:288980) Using Debt Sensibly?
Mar 04Moadata Co., Ltd. (KOSDAQ:288980) May Have Run Too Fast Too Soon With Recent 32% Price Plummet
Dec 09Would Moadata (KOSDAQ:288980) Be Better Off With Less Debt?
Nov 28Solid Earnings Reflect Moadata's (KOSDAQ:288980) Strength As A Business
Aug 26We Think Moadata (KOSDAQ:288980) Has A Fair Chunk Of Debt
Jul 02Moadata Co., Ltd. Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -262.76
- Gross Margin
- 40.21%
- Net Profit Margin
- -28.37%
- Debt/Equity Ratio
- 116.4%
Moadata Co., Ltd. Competitors
Snowflake Analysis
About A288980
- Founded
- 2014
- Employees
- 62
- CEO
- WebsiteView website
Moadata Co., Ltd., an artificial intelligence company, provides ICT infrastructure monitoring and healthcare solutions in South Korea. It offers PETAON Forecaster, an ICT infrastructure monitoring solution that collects real-time data and detects anomalies in the server; and FLOFIT, an artificial intelligence-based personalized health care service that collects and analyzes body information collected in real time through wearable devices. The company was founded in 2014 and is based in headquartered in Seongnam, South Korea.
Market Insight
Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading
South Korean Market Performance
- 7 Days: 3.3%
- 3 Months: 13.3%
- 1 Year: 32.8%
- Year to Date: 44.6%
The market is up 3.3% over the last week, with the Information Technology sector leading the way, up 7.1%. As for the past 12 months, the market is up 33%. Looking forward, earnings are forecast to grow by 24% annually. Market details ›